Understanding Fentanyl Citrate Injection Formulations in the UK: A Clinical Overview
Fentanyl citrate stays among the most crucial tools in contemporary anaesthesia and sharp pain management across the United Kingdom. As a powerful artificial opioid, its function in the National Health Service (NHS) and personal surgical sectors is well-established, mostly due to its quick onset of action and cardiovascular stability. This post offers a thorough introduction of fentanyl citrate injection solutions offered in the UK, their scientific signs, regulatory landscape, and administration procedures.
What is Fentanyl Citrate?
Fentanyl citrate is a potent phenylpiperidine-derivative opioid agonist. It was first synthesized in 1960 and rapidly became a cornerstone of perioperative care. In terms of strength, fentanyl is roughly 50 to 100 times more potent than morphine. Its high lipophilicity allows it to cross the blood-brain barrier quickly, leading to a practically instant analgesic result when administered intravenously.
In the UK, fentanyl citrate is predominantly used by means of the parenteral path (injection) for both sedative and analgesic purposes. It works mostly by binding to the mu-opioid receptors in the main nerve system, modifying the perception of pain and the emotional action to it.
Clinical Indications in the UK
According to the British National Formulary (BNF), fentanyl citrate injection is suggested for a number of specific medical circumstances:
- Analgesic Action: Used throughout brief operative procedures and in the healing space.
- Analgesic Supplement: Used throughout the induction and maintenance of inhalation anaesthesia.
- Neuroleptanalgesia: Often utilized in combination with a neuroleptic (such as droperidol) to achieve a state of quiescence and reduced awareness.
- Management of Severe Pain: Particularly in the Intensive Care Unit (ICU) for patients on mechanical ventilation.
- Pre-medication: To supply sedation and analgesia before the induction of general anaesthesia.
Available Formulations and Strengths in the UK
The UK market provides numerous formulas of fentanyl citrate, designed to fulfill the differing requirements of surgical and emergency situation departments. visit website are generally presented as clear, colourless solutions for injection or infusion.
Table 1: Common Fentanyl Citrate Formulations in the UK
| Strength (Fentanyl base) | Presentation | Typical Packaging | Maker Examples |
|---|---|---|---|
| 50 micrograms/ml | 2 ml Ampoule | Pack of 10 | Hameln, Advanz Pharma |
| 50 micrograms/ml | 10 ml Ampoule | Pack of 5 or 10 | Hameln, Wockhardt |
| 50 micrograms/ml | 20 ml Vial/Ampoule | Pack of 5 | Hameln, Generic |
| 50 micrograms/ml | 50 ml Vial | Individual/Pack of 1 | Generic (ICU use) |
Note: While 50 mcg/ml is the standard concentration, specialised formulas for epidural or intrathecal usage might sometimes be prepared by healthcare facility pharmacies under specific procedures.
Pharmacokinetics and Pharmacodynamics
Comprehending how the body processes fentanyl is crucial for safe administration.
- Beginning of Action: When administered intravenously, the effect begins nearly immediately, though the maximal analgesic impact might take 3 to 5 minutes.
- Duration: A single intravenous dose of 100 micrograms generally lasts for 30 to 60 minutes.
- Metabolism: Fentanyl is mostly metabolised in the liver by means of the CYP3A4 enzyme system.
- Excretion: Approximately 75% of the dosage is excreted in the urine within 24 hours, primarily as metabolites.
Administration Protocols
In the UK, the administration of fentanyl citrate is strictly managed and usually carried out by anaesthetists or trained specialists in controlled environments.
Dose Guidelines
Dose needs to be horizontal and individualised based upon the client's age, weight, physical status, underlying pathological condition, use of other drugs, and the type of surgery.
- Low Dose (2 mcg/kg): Useful for minor surgical procedures.
- Moderate Dose (2-- 20 mcg/kg): Used when surgery is more intrusive; requires respiratory tracking.
- High Dose (20-- 50 mcg/kg): Used throughout "trouble-free" significant surgical procedures (e.g., open-heart surgical treatment) to protect the myocardium from the metabolic demands of tension.
Paths of Administration
- Intravenous (IV) Bolus: Common for induction.
- Intravenous Infusion: Used for longer procedures or in the ICU.
- Intramuscular (IM): Less typical, however utilized for pre-medication in particular circumstances.
Regulatory Status and Safety
In the United Kingdom, Fentanyl is categorized under the Misuse of Drugs Act 1971 as a Class A drug. Under the Misuse of Drugs Regulations 2001, it is classified as a Schedule 2 Controlled Drug (CD POM).
Statutory Requirements for UK Hospitals:
- Safe Custody: Must be saved in a locked controlled drug cupboard.
- Record Keeping: Every administration must be taped in a Controlled Drugs Register (CDR).
- Destruction: Surplus or ended fentanyl should be denatured and experienced by authorised personnel.
Adverse Effects and Adverse Reactions
While extremely effective, fentanyl citrate carries a danger of substantial side effects.
- Breathing Depression: The most major adverse effects, which can lead to respiratory arrest if not kept track of.
- Bradychardia: Often managed with atropine.
- Muscle Rigidity (Chest Wall Rigidity): High doses can make ventilation hard, needing making use of neuromuscular blocking agents.
- Nausea and Vomiting: Common in the postoperative period.
- Hypotension: Although more stable than morphine, it can still happen, particularly in hypovolaemic clients.
Contrast with Other Opioids
Clinicians often pick fentanyl over other opioids due to its particular pharmacokinetic profile.
Table 2: Comparison of Parenteral Opioids in UK Practice
| Function | Fentanyl | Morphine | Remifentanil |
|---|---|---|---|
| Relative Potency | 100 | 1 | 100-200 |
| Beginning | 1-- 3 minutes | 15-- 30 minutes | 1 minute |
| Duration of Action | 30-- 60 minutes | 3-- 4 hours | 5-- 10 minutes |
| Histamine Release | Negligible | Significant | Negligible |
| Primary Use | Intraoperative/ICU | Post-operative/Chronic | Titratable Infusion |
Regularly Asked Questions (FAQ)
1. Is fentanyl citrate injection the like the fentanyl patches?
No. While they contain the same active drug, the injection is for immediate, acute usage in surgical or emergency settings. Patches (transdermal delivery) are developed for chronic, long-term pain management and release the medication slowly over 72 hours.
2. Can fentanyl citrate be used for children in the UK?
Yes, it is often utilized in paediatric anaesthesia. However, the dosage should be strictly computed based upon the kid's weight, and they must be monitored closely for respiratory depression.
3. What is the antagonist for fentanyl?
Naloxone is the particular pharmacological antagonist used to reverse the results of fentanyl, including respiratory anxiety. In UK health centers, naloxone needs to always be readily offered any place fentanyl is administered.
4. Why is it utilized over morphine in heart surgical treatment?
Fentanyl is chosen in heart surgical treatment due to the fact that it does not cause the release of histamine, which can lead to vasodilation and hypotension. It supplies cardiovascular stability even at high doses.
5. What are the storage requirements?
Fentanyl citrate injection need to be stored below 25 ° C and safeguarded from light. As a Schedule 2 drug, it must be kept in a lawfully compliant CD cupboard.
Fentanyl citrate injection solutions are vital components of the UK's medical toolkit for managing perioperative pain and assisting in complex surgical treatments. Its high effectiveness and rapid beginning deal unmatched precision for anaesthetists, offered that strenuous monitoring and regulatory requirements are maintained. By understanding the different concentrations and the rigorous protocols surrounding its usage, healthcare specialists ensure that this effective medication remains both safe and effective for clients throughout the country.
Disclaimer: This post is for informative functions just and does not constitute medical recommendations. Healthcare specialists should always refer to the Summary of Product Characteristics (SmPC) and existing BNF guidelines for the most current recommending details.
